Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000191626
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
336711
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
||
|
WHO-ATC |
M09AX07
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
||
|
NDF-RT |
N0000193222
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5207
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
m11974
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
10003
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL3301572
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
1863556
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
NUSINERSEN
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
AB-110
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
5Z9SP3X666
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
5Z9SP3X666
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
C166875
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
SUB182823
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
DTXSID301027785
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
DB13161
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
1258984-36-9
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY | |||
|
100000169172
Created by
admin on Mon Mar 31 22:34:40 GMT 2025 , Edited by admin on Mon Mar 31 22:34:40 GMT 2025
|
PRIMARY |
| Sugar | Site Range | Site Count |
|---|---|---|
| 2-O-beta-hydroxy-ethoxy-methyl Ribose (Qiagen) | 1_1-1_18 | 18 / 18 |
| Linkage | Site Range | Site Count |
|---|---|---|
| Phosporothioate | 1_2-1_18 | 17 / 17 |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)